Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 1/2 2Phase NA 1Phase 1 1

Status

Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Spondylitis, Ankylosing 1Signs and Symptoms 1Lymphoma 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 648Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Sulfasalazine × Clear all
NCT03847311 2025-01-09

Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients

University of Arizona

Phase 2 Completed
7 enrolled 8 charts
Breast

Breast Neoplasms, Signs and Symptoms

NCT06557330 2025-01-06

MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma

Fox Chase Cancer Center

Phase 2 Not yet recruiting
24 enrolled
Lymphoid

Lymphoma

NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡